Histomorphometric comparison of cardiac allograft vasculopathy in miniature swine

Journal of Heart and Lung Transplantation

Volumn 23, Issue 1, 2004, Pages 50-60

  Houser, Stuart L ^a   McMorrow, Isabel M ^a   Leguern, Christian ^a   Schwarze, Margaret L ^a   Fuchimoto, Yasuli ^a   Sachs, David H ^a   Madsen, Joren C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CELL NUCLEUS ANTIGEN; CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CELL PROLIFERATION; CHIMERA; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; EXPLANT; GENE EXPRESSION; GRAFT REJECTION; HEART GRAFT; HEART MUSCLE; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HISTOCOMPATIBILITY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTIMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MORPHOMETRICS; NICK END LABELING; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; SMOOTH MUSCLE; SPINDLE CELL; SWINE; VASCULAR LESION;

EID: 0346008035     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00065-2     Document Type: Article

References (38)

1. Shirwan H. Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role? Transplantation. 68:1999;715-726.
2. Van Buskirk A.M., Pidwell D.J., Adams P.W., Orosz C.H. Transplantation immunology. JAMA. 278:1997;1993-1999.
3. Andersen H.O. Heart allograft vascular disease, an obliterative vascular disease in transplanted hearts. Atherosclerosis. 142:1999;243-263.
4. Thomson J.G. Production of severe atheroma in a transplanted human heart. Lancet. 2:1969;1088-1092.
5. Haverich A. Cyclosporine in heart transplantation. Transplant Proc. 24:1992;82-84.
6. Sachs D.H., Leight G., Cone J., Schwarz S., Stuart L., Rosenberg S. Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation. 22:1976;559-567.
7. Schwarze M.L., Menard M., Fuchimoto Y., et al. Mixed hematopoietic chimerism induces long term tolerance to cardiac allografts in miniature swine. Ann Thorac Surg. 70:2000;131-138.
8. Madsen J.C., Sachs D.H., Fallon J.T., Weissman N.J. Cardiac allograft vasculopathy in partially inbred miniature swine. 1. Time course, pathology and dependence on immune mechanisms. J Thorac Cardiovasc Surg. 111:1996;1230-1239.
9. Pennington L.R., Lunney J.K., Sachs D.H. Transplantation in miniature swine VIII - recombination within the major histocompatibility complex of miniature swine . Transplantation. 31:1981;66-75.
10. Blancho G., Gianello P., Germana S., Baetscher M., Sachs D.H., LeGuern C. Molecular identification of porcine interleukin 10 regulation of expression in a kidney allograft model . Proc Natl Acad Sci U S A. 92:1995;2800-2804.
11. Billingham M.E., Cary N.R.B., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection Heart Rejection Study Group . J Heart Transplant. 9:1990;587-593.
12. Salomon R., Hughes C., Schoen F., Payne D., Pober J., Libby P. Human coronary transplantation-associated arteriosclerosis. Am J Pathol. 138:1991;791-798.
13. Muller D.W.M., Ellis S.G., Topol E.J. Experimental models of coronary artery restenosis. J Am Coll Cardiol. 19:1992;418-432.
14. Madsen J. Cardiac allograft vasculopathy in miniature swine utility of a large animal model . Graft. I:1998;II41-II44.
15. Clausell N., Molossi S., Rabinovitch M. Increased interleukin-1B and fibronectin expression are early features of the development of the postcardiac transplant coronary arteriopathy in piglets. Am J Pathol. 142:1993;1772-1786.
16. Choo, J.K., Seegach J.D., Nickeleit V., et al. Species differences in the expression of major histocompatibility complex class II antigens on coronary artery endothelium. Transplantation. 64:1997;1315-1322.
17. Allan J.S., Choo J.K., Vesga L., et al. Cardiac allograft vasculopathy is abrogated by anti-CD8 monoclonal antibody therapy. Ann Thorac Surg. 64:1997;1019-1025.
18. Madsen J.C., Yamad K., Allan J.S., et al. Transplantation tolerance prevents cardiac allograft vasculopathy in major histocompatibility complex class I-disparate miniature swine. Transplantation. 65:1998;304-313.
19. Oho S., Rabinovitch M. Post-cardiac transplant arteriopathy in piglets is associated with fragmentation of elastin and increased activity of a serine elastase. Am J Pathol. 145:1994;202-210.
20. Perrault L.P., Bidouard J.P., Janiak P., et al. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation. J Heart Lung Transplant. 16:1997;643-657.
21. McManus B.M., Horley K.J., Wilson J.E., et al. Prominence of coronary arterial wall lipids in human heart allografts. Am J Pathol. 147:1995;293-308.
22. Billingham M.E. Cardiac transplant atherosclerosis. Transplant Proc. 19:1987;19-25.
23. Dec G.W. Cardiac transplantation. Ginns L.C., Cosimi A.B., Morris P.J. Transplantation. 1999;461-462 Blackwell Science, Malden, MA.
24. Dong C., Wilson J.E., Winters G.L., McManus B.M. Human transplant coronary artery disease pathological evidence for fas-mediated apoptotic cytotoxicity in allograft arteriopathy . Lab Invest. 74:1996;921-931.
25. Dong C., Granville D.J., Tuffnel C.E., et al. Bax and apoptosis in acute and chronic rejection of rat cardiac allografts. Lab Invest. 79:1999;1643-1653.
26. Lurie K.G., Billingham M.E., Jamieson S.W., Harrison D.C., Reitz B.A. Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model. Transplantation. 31:1981;41-47.
27. Kawaharada N., Shears L.L.I.I., Li S., Pham S.M. Mixed hematopoietic chimerism prevents allograft vasculopathy. J Heart Lung Transplant. 18:1999;532-541.
28. Nagano H., Mitchell R.N., Taylor M.K., Hasegawa S., Tilney N.L., Libby P. Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest. 100:1997;550-557.
29. Raisanen-Sokolowski A., Glysing-Jensen T., Koglin J., Russell M.E. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-γ knockout recipients. Am J Pathol. 152:1998;359-365.
30. Wang X., Yue T.L., Ohlstein E.H., Sung C.P., Feuerstein G.Z. Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J Biol Chem. 271:1996;24286-24293.
31. Melter M., Exeni A., Reinders M.E., et al. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation. 104:2001;2558-2564.
32. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 147:1991;3815-3822.
33. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin 10. J Exp Med. 174:1991;1549-1555.
34. Danzer S.G., Kirchner H., Rink L. Cytokine interactions in human mixed lymphocyte culture. Transplantation. 57:1994;1638-1642.
35. Taga K., Tosato G. IL-10 inhibits human T cell and IL-2 production. J Immunol. 148:1992;1143-1148.
36. Ding L., Shevach E.M. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol. 148:1992;3133-3139.
37. Furukawa Y., Becker G., Stinn J.L., Shimizu K., Libby P., Mitchell R.N. Interleukin-10 augments allograft arterial disease. Am J Pathol. 155:1999;1929-1939. (IL-10).
38. Hillebrands J.L., Raué H.P., Klatter F.A., et al. Intrathymic immune modulation prevents acute rejection but not the development of graft arteriosclerosis. Transplantation. 71:2001;914-924. (chronic rejection).